Literature DB >> 17171565

Development of an immunochromatographic test with recombinant BgSA1 for the diagnosis of Babesia gibsoni infection in dogs.

Honglin Jia1, Min Liao, Eunggoo Lee, Yoshifumi Nishikawa, Hisashi Inokuma, Hiromi Ikadai, Aya Matsuu, Ikuo Igarashi, Xuenan Xuan.   

Abstract

An immunochromatographic test (ICT) using recombinant BgSA1 (rBgSA1) for the detection of antibodies against Babesia gibsoni was developed and evaluated. Only the serum samples collected from dogs infected with B. gibsoni were positive in the ICT, but the serum samples from dogs infected with closely related parasites and from healthy dogs were negative. The specific antibodies could be detected in a dog experimentally infected with B. gibsoni at both the acute and chronic infection stages by the ICT. To evaluate the clinical application of the ICT, a total of 94 serum samples collected from domestic dogs in Japan were tested with the ICT and the previously established enzyme-linked immunosorbent assay (ELISA) with rBgSA1. Twenty-one of the tested samples (22.3%) were positive in both the ICT and the ELISA. The concordance between the ELISA and the ICT was found to be 95.8%. These results suggested that the ICT using rBgSA1 is rapid, simple, accurate, and suitable for the diagnosis of B. gibsoni infection of dogs in the field.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17171565     DOI: 10.1007/s00436-006-0392-8

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  14 in total

1.  Babesia gibsoni infection among dogs in the southeastern United States.

Authors:  Douglass K Macintire; Mary K Boudreaux; Gretchen D West; Candace Bourne; James C Wright; Patricia A Conrad
Journal:  J Am Vet Med Assoc       Date:  2002-02-01       Impact factor: 1.936

2.  Babesia gibsoni infection in three dogs in Victoria.

Authors:  C J Muhlnickel; R Jefferies; U M Morgan-Ryan; P J Irwin
Journal:  Aust Vet J       Date:  2002-10       Impact factor: 1.281

3.  Epidemiological survey of Babesia gibsoni infection in dogs in eastern Japan.

Authors:  Takako Miyama; Yoshimi Sakata; Yojiro Shimada; Shoji Ogino; Malaika Watanabe; Kazuhito Itamoto; Masaru Okuda; Rodolfo A Verdida; Xuenan Xuan; Hideyuki Nagasawa; Hisashi Inokuma
Journal:  J Vet Med Sci       Date:  2005-05       Impact factor: 1.267

4.  Piroplasma infection in dogs in northern Spain.

Authors:  Angel Tomás Camacho García
Journal:  Vet Parasitol       Date:  2006-02-28       Impact factor: 2.738

5.  There are at least three genetically distinct small piroplasms from dogs.

Authors:  A M Kjemtrup; A A Kocan; L Whitworth; J Meinkoth; A J Birkenheuer; J Cummings; M K Boudreaux; S L Stockham; A Irizarry-Rovira; P A Conrad
Journal:  Int J Parasitol       Date:  2000-12       Impact factor: 3.981

6.  Morphological changes of Babesia gibsoni grown in canine red blood cell-substituted severe combined immune deficiency mice.

Authors:  S Fukumoto; X Xuan; I Igarashi; S Zhang; J Mugisha; T Ogata; H Nagasawa; K Fujisaki; N Suzuki; T Mikami
Journal:  J Parasitol       Date:  2000-10       Impact factor: 1.276

7.  Identification of a novel gene encoding a secreted antigen 1 of Babesia gibsoni and evaluation of its use in serodiagnosis.

Authors:  Honglin Jia; Jinlin Zhou; Hiromi Ikadai; Aya Matsuu; Hiroshi Suzuki; Ikuo Igarashi; Kozo Fujisaki; Xuenan Xuan
Journal:  Am J Trop Med Hyg       Date:  2006-11       Impact factor: 2.345

Review 8.  Canine babesiosis.

Authors:  A Lindsay Boozer; Douglass K Macintire
Journal:  Vet Clin North Am Small Anim Pract       Date:  2003-07       Impact factor: 2.093

Review 9.  A review of the small canine piroplasms from California: Babesia conradae in the literature.

Authors:  Anne M Kjemtrup; Patricia A Conrad
Journal:  Vet Parasitol       Date:  2006-03-07       Impact factor: 2.738

10.  Serodiagnosis of canine Babesia gibsoni infection by enzyme-linked immunosorbent assay with recombinant P50 expressed in Escherichia coli.

Authors:  Shinya Fukumoto; Yukiko Sekine; Xuenan Xuan; Ikuo Igarashi; Chihiro Sugimoto; Hideyuki Nagasawa; Kozo Fujisaki; Takeshi Mikami; Hiroshi Suzuki
Journal:  J Parasitol       Date:  2004-04       Impact factor: 1.276

View more
  6 in total

1.  Identification of secreted antigen 3 from Babesia gibsoni.

Authors:  Honglin Jia; M Alaa Terkawi; Gabriel Oluga Aboge; Youn-Kyoung Goo; Liqing Ma; Jinlin Zhou; Yoshifumi Nishikawa; Ikuo Igarashi; Kozo Fujisaki; Xuenan Xuan
Journal:  Clin Vaccine Immunol       Date:  2009-04-22

Review 2.  Current advances in detection and treatment of babesiosis.

Authors:  J Mosqueda; A Olvera-Ramirez; G Aguilar-Tipacamu; G J Canto
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

3.  A novel promising diagnostic candidate selected by screening the transcriptome of Babesia gibsoni (Wuhan isolate) asexual stages in infected beagles.

Authors:  Jiaying Guo; Furong Yang; Lingna Wang; Xuenan Xuan; Junlong Zhao; Lan He
Journal:  Parasit Vectors       Date:  2022-10-10       Impact factor: 4.047

Review 4.  New Molecules in Babesia gibsoni and their application for diagnosis, vaccine development, and drug discovery.

Authors:  Youn-Kyoung Goo; Xuenan Xuan
Journal:  Korean J Parasitol       Date:  2014-08-29       Impact factor: 1.341

5.  Molecular identification and antigenic characterization of a merozoite surface antigen and a secreted antigen of Babesia canis (BcMSA1 and BcSA1).

Authors:  Mo Zhou; Shinuo Cao; Yuzi Luo; Mingming Liu; Guanbo Wang; Paul Franck Adjou Moumouni; Charoonluk Jirapattharasate; Aiko Iguchi; Patrick Vudriko; Mohamad Alaa Terkawi; Mario Löwenstein; Angela Kern; Yoshifumi Nishikawa; Hiroshi Suzuki; Ikuo Igarashi; Xuenan Xuan
Journal:  Parasit Vectors       Date:  2016-05-03       Impact factor: 3.876

Review 6.  The Etiology, Incidence, Pathogenesis, Diagnostics, and Treatment of Canine Babesiosis Caused by Babesia gibsoni Infection.

Authors:  Martina Karasová; Csilla Tóthová; Simona Grelová; Mária Fialkovičová
Journal:  Animals (Basel)       Date:  2022-03-16       Impact factor: 2.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.